VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model.

MLA

Zhang, Huiyong, et al. “VEGF165b Mutant with a Prolonged Half-Life and Enhanced Anti-Tumor Potency in a Mouse Model.” Journal of Biotechnology, vol. 284, Oct. 2018, pp. 84–90. EBSCOhost, https://doi.org/10.1016/j.jbiotec.2018.08.002.

APA

Zhang, H., Jia, E., Xia, W., Lu, C., & Zhu, W. (2018). VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model. Journal of Biotechnology, 284, 84–90. https://doi.org/10.1016/j.jbiotec.2018.08.002

Chicago

Zhang, Huiyong, Enchao Jia, Wenjiao Xia, Chengui Lu, and Wuling Zhu. 2018. “VEGF165b Mutant with a Prolonged Half-Life and Enhanced Anti-Tumor Potency in a Mouse Model.” Journal of Biotechnology 284 (October): 84–90. doi:10.1016/j.jbiotec.2018.08.002.